PL368727A1 - 17alfa-hydroksy-14beta-steroidy o działaniu hormonalnym - Google Patents

17alfa-hydroksy-14beta-steroidy o działaniu hormonalnym

Info

Publication number: PL368727A1
Authority: PL; Poland
Prior art keywords: 14beta; 17alpha; steroids; hydroxy; hormonal effect
Prior art date: 2001-09-12

Application number

PL02368727A

Other languages

English (en)

Other versions

PL207493B1 (pl

Inventor

Der Louw Jaap Van

Dirk Leysen

Gooijer Marcel Evert De

Original Assignee

Akzo Nobel N.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-12

Filing date

2002-09-06

Publication date

2005-04-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8180920&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL368727(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-09-06 Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.

2005-04-04 Publication of PL368727A1 publication Critical patent/PL368727A1/pl

2010-12-31 Publication of PL207493B1 publication Critical patent/PL207493B1/pl

Links

230000003054 hormonal effect Effects 0.000 title 1
231100000508 hormonal effect Toxicity 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL368727A 2001-09-12 2002-09-06 17α-hydroksy-14β-steroidy i ich zastosowanie PL207493B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP01203455		2001-09-12

Publications (2)

Publication Number	Publication Date
PL368727A1 true PL368727A1 (pl)	2005-04-04
PL207493B1 PL207493B1 (pl)	2010-12-31

Family

ID=8180920

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL368727A PL207493B1 (pl)	2001-09-12	2002-09-06	17α-hydroksy-14β-steroidy i ich zastosowanie

Country Status (28)

Country	Link
US (1)	US7169769B2 (pl)
EP (1)	EP1427748B1 (pl)
JP (1)	JP4471653B2 (pl)
KR (1)	KR100940054B1 (pl)
CN (1)	CN1257913C (pl)
AR (1)	AR036462A1 (pl)
AT (1)	ATE395352T1 (pl)
AU (1)	AU2002339536B2 (pl)
BR (1)	BR0212409A (pl)
CA (1)	CA2505575C (pl)
CY (1)	CY1108152T1 (pl)
DE (1)	DE60226623D1 (pl)
DK (1)	DK1427748T3 (pl)
EC (1)	ECSP045012A (pl)
ES (1)	ES2305306T3 (pl)
HR (1)	HRP20040193A2 (pl)
HU (1)	HUP0402139A3 (pl)
IL (2)	IL160451A0 (pl)
IS (1)	IS2555B (pl)
MX (1)	MXPA04002418A (pl)
NO (1)	NO326624B1 (pl)
NZ (1)	NZ531487A (pl)
PL (1)	PL207493B1 (pl)
PT (1)	PT1427748E (pl)
RU (1)	RU2294332C2 (pl)
TW (1)	TWI221154B (pl)
WO (1)	WO2003022864A1 (pl)
ZA (1)	ZA200401992B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI221154B (en)	2001-09-12	2004-09-21	Akzo Nobel Nv	17alpha-hydroxy-14beta-steroids with hormonal effect

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3338925A (en) *	1965-10-25	1967-08-29	Syntex Corp	17-substituted 14beta-estr-4-enes
WO2000053619A1 (en) *	1999-03-08	2000-09-14	Akzo Nobel N.V.	14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens
AU4299301A (en) *	2000-02-29	2001-09-12	National University Of Singapore, The	A method for modulating steroidogenic activity
US6391868B2 (en) *	2000-05-10	2002-05-21	Lpt Research, Inc.	Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans
TWI221154B (en)	2001-09-12	2004-09-21	Akzo Nobel Nv	17alpha-hydroxy-14beta-steroids with hormonal effect

2002
- 2002-07-19 TW TW091116164A patent/TWI221154B/zh not_active IP Right Cessation
- 2002-09-06 US US10/489,456 patent/US7169769B2/en not_active Expired - Lifetime
- 2002-09-06 ES ES02777036T patent/ES2305306T3/es not_active Expired - Lifetime
- 2002-09-06 KR KR1020047003609A patent/KR100940054B1/ko not_active Expired - Fee Related
- 2002-09-06 AU AU2002339536A patent/AU2002339536B2/en not_active Expired
- 2002-09-06 PT PT02777036T patent/PT1427748E/pt unknown
- 2002-09-06 MX MXPA04002418A patent/MXPA04002418A/es active IP Right Grant
- 2002-09-06 HU HU0402139A patent/HUP0402139A3/hu unknown
- 2002-09-06 WO PCT/EP2002/010041 patent/WO2003022864A1/en not_active Ceased
- 2002-09-06 HR HR20040193A patent/HRP20040193A2/hr not_active Application Discontinuation
- 2002-09-06 IL IL16045102A patent/IL160451A0/xx unknown
- 2002-09-06 AT AT02777036T patent/ATE395352T1/de active
- 2002-09-06 JP JP2003526937A patent/JP4471653B2/ja not_active Expired - Fee Related
- 2002-09-06 DE DE60226623T patent/DE60226623D1/de not_active Expired - Lifetime
- 2002-09-06 BR BR0212409-2A patent/BR0212409A/pt not_active IP Right Cessation
- 2002-09-06 DK DK02777036T patent/DK1427748T3/da active
- 2002-09-06 EP EP02777036A patent/EP1427748B1/en not_active Expired - Lifetime
- 2002-09-06 NZ NZ531487A patent/NZ531487A/en not_active IP Right Cessation
- 2002-09-06 RU RU2004110934/04A patent/RU2294332C2/ru not_active IP Right Cessation
- 2002-09-06 PL PL368727A patent/PL207493B1/pl not_active IP Right Cessation
- 2002-09-06 CN CNB02817853XA patent/CN1257913C/zh not_active Expired - Lifetime
- 2002-09-06 CA CA2505575A patent/CA2505575C/en not_active Expired - Lifetime
- 2002-09-10 AR ARP020103415A patent/AR036462A1/es unknown
2004
- 2004-02-18 IL IL160451A patent/IL160451A/en not_active IP Right Cessation
- 2004-02-26 IS IS7165A patent/IS2555B/is unknown
- 2004-03-10 NO NO20041010A patent/NO326624B1/no not_active IP Right Cessation
- 2004-03-10 EC EC2004005012A patent/ECSP045012A/es unknown
- 2004-03-11 ZA ZA200401992A patent/ZA200401992B/en unknown
2008
- 2008-06-19 CY CY20081100653T patent/CY1108152T1/el unknown

Also Published As

Publication number	Publication date
HK1063637A1 (en)	2005-01-07
EP1427748B1 (en)	2008-05-14
HUP0402139A3 (en)	2012-12-28
HUP0402139A2 (hu)	2005-02-28
CN1257913C (zh)	2006-05-31
HRP20040193A2 (en)	2004-08-31
IL160451A (en)	2009-11-18
PL207493B1 (pl)	2010-12-31
IL160451A0 (en)	2004-07-25
IS7165A (is)	2004-02-26
CA2505575A1 (en)	2003-03-20
NZ531487A (en)	2005-08-26
ECSP045012A (es)	2004-09-27
KR20040039346A (ko)	2004-05-10
DE60226623D1 (de)	2008-06-26
US7169769B2 (en)	2007-01-30
WO2003022864A1 (en)	2003-03-20
RU2294332C2 (ru)	2007-02-27
AU2002339536B2 (en)	2008-04-24
JP4471653B2 (ja)	2010-06-02
EP1427748A1 (en)	2004-06-16
AR036462A1 (es)	2004-09-08
CA2505575C (en)	2010-01-26
PT1427748E (pt)	2008-08-27
BR0212409A (pt)	2004-08-03
CN1553917A (zh)	2004-12-08
MXPA04002418A (es)	2004-07-30
IS2555B (is)	2009-10-15
CY1108152T1 (el)	2014-02-12
ATE395352T1 (de)	2008-05-15
US20040259849A1 (en)	2004-12-23
KR100940054B1 (ko)	2010-02-04
NO326624B1 (no)	2009-01-19
ES2305306T3 (es)	2008-11-01
ZA200401992B (en)	2005-04-21
TWI221154B (en)	2004-09-21
RU2004110934A (ru)	2005-08-20
DK1427748T3 (da)	2008-09-08
NO20041010L (no)	2004-03-10
JP2005505566A (ja)	2005-02-24

Legal Events

Date	Code	Title	Description
2013-10-31	LAPS	Decisions on the lapse of the protection rights	Effective date: 20120906

Publication	Publication Date	Title
DE50202400D1 (en)	2005-04-07	Baw-resonator
DE60213216D1 (en)	2006-08-31	Metalloproteinaseinhibitoren
DE60231477D1 (en)	2009-04-23	Imidazolderivate
GB2392916B (en)	2005-02-16	Deicing
DE60223825D1 (en)	2008-01-10	Ethynylierungsverfahren
DE60231872D1 (en)	2009-05-20	Echinocandinverfahren
GB0119103D0 (en)	2001-09-26	Travelbib
GB0105113D0 (en)	2001-04-18	Punchbag
AU2002313943A8 (en)	2008-01-03	Electromobile
GB0100862D0 (en)	2001-02-21	Reflactron
GB0114007D0 (en)	2001-08-01	Oilgonucleotides
PL368727A1 (pl)	2005-04-04	17alfa-hydroksy-14beta-steroidy o działaniu hormonalnym
GB0112539D0 (en)	2001-07-11	Sleepover
GB0117479D0 (en)	2001-09-12	Jetters
GB0112053D0 (en)	2001-07-11	Bacsac
GB0105580D0 (en)	2001-04-25	Pile-breaker
AU2288P (en)	2004-07-28	Prime322 xTriticosecale
GB0110942D0 (en)	2001-06-27	Vita-tea
GB0104363D0 (en)	2001-04-11	Slip-a-shoe
GB0112931D0 (en)	2001-07-18	Zimzima
GB0111335D0 (en)	2001-07-04	Scooter-bike
GB0116101D0 (en)	2001-08-22	Track-master
GB0109830D0 (en)	2001-06-13	Style-flow
GB0108832D0 (en)	2001-05-30	Chuckmate
GB0108173D0 (en)	2001-05-23	Helmlight